ライフサイエンスコーパス: risk-taking

1 t not dorsal, striatum induced a decrease in risk taking.

2 ne self-administration causes alterations in risk taking.

3 t that may help explain seemingly irrational risk taking.

4 ulus correlated significantly with increased risk taking.

5 bility discounting is a measurable aspect of risk taking.

6 ralleling human regulatory focus research on risk taking.

7 ns, aggressive attitudes, and preference for risk taking.

8 he role of the endocrine system in financial risk taking.

9 s before a gambling task increased financial risk taking.

10 ibutes to success in real-world, high-stakes risk taking.

11 lator could lead to the observed decrease in risk taking.

12 modulate longitudinal declines in adolescent risk taking.

13 he PFC disparately contribute to declines in risk taking.

14 illuminate effects of population dynamics on risk-taking.

15 decision-making captured in impulsivity and risk-taking.

16 nd how this relates to trait impulsivity and risk-taking.

17 ng, alcohol and illicit drug use, and sexual risk-taking.

18 nerability marker for mania and pathological risk-taking.

19 dorsal striatum were associated with greater risk-taking.

20 in adulthood that negatively correlate with risk-taking.

21 found no evidence for a consistent change in risk taking across the lifespan [5].

22 Behavioral data showed reduced risk taking after negative feedback (money loss) during

23 ipitation and seasonal dynamics on pesticide risk taking also concentrations below the limit of quant

24 ly exhibit proclivity for reward seeking and risk taking, also has yielded some insight.

25 rstanding factors that are related to sexual risk taking among virologically detectable (VL+) YMSM ca

26 Systemic amphetamine also reduced risk-taking, an effect which was attenuated by D2-like (

27 icate that the relationship between elevated risk taking and cocaine self-administration is bi-direct

28 l and hypothetical monetary rewards modulate risk taking and decision making in the same manner remai

29 ry rewards are widely used as reinforcers in risk taking and decision making studies.

30 hypothetical monetary rewards in studies of risk taking and decision making.

31 ability weighting functions underlying their risk taking and found that participants became more risk

32 Risk taking and functional and structural properties of

33 interest is dopamine's influence on economic risk taking and on subjective well-being, a quantity kno

34 ighlighted the relationship between personal risk taking and population risk.

35 of errors during set shifting and increased risk taking and reduced FA in uncinate fasciculus correl

36 red formation of long-term memory, increased risk taking and stimulus seeking behavior, enhanced susc

37 d physiological traits--such as impulsivity, risk taking and stress responsivity--as well as a substa

38 ty to emotional faces may contribute to less risk taking and susceptibility to peer influence in adol

39 vides a possible neural mechanism explaining risk-taking and impaired reinforcement learning in BD.

40 re/exploit trade-off encompasses elements of risk-taking and impulsivity-common behaviors in psychiat

41 (GM), and test whether modernization, sexual risk-taking and parity are associated with greater risk

42 ls of endogenous cortisol predict subsequent risk-taking and price instability.

43 ce were hyperactive and showed more frequent risk-taking and repetitive behaviors, less depression-li

44 examined how modernization influences sexual risk-taking and reproductive health early in demographic

45 Sexual risk-taking and reproductive morbidity are common among

46 ongitudinal analysis provides new insight in risk-taking and reward sensitivity in adolescence: (1) c

47 sing effects of modernization on both sexual risk-taking and risk of GM.

48 motor learning, hyperactivity, and increased risk-taking and self-injurious behaviors.

49 -report and testosterone levels), laboratory risk-taking and self-reported risk-taking tendency; and

50 es, a combination suggested to contribute to risk-taking and susceptibility to peer influence during

51 We find that increased risk-taking and the publication of experimental failures

52 ciated with impaired set shifting, increased risk taking, and impaired integrity of frontolimbic whit

53 lite levels and measures of decision making, risk taking, and impulsivity in smokers and nonsmokers h

54 e was additionally associated with real-life risk taking, and N1 source activity was reduced in visua

55 al predictor of future excessive aggression, risk taking, and premature death among nonhuman primate

56 cuss hypotheses involving "self-medication," risk-taking, and changes in the social climate but concl

57 nsions of emotionality, such as impulsivity, risk-taking, and drug abuse.

58 s characterised by increased impulsivity and risk-taking, and psychological accounts argue that these

59 levels with neurocognitive, decision-making, risk-taking, and self-reported impulsivity measures were

60 Indeed, pathological impulsivity and risk taking are common in patients with serious mental i

61 The reasons for risk taking are multifactorial and require providers to

62 ievement since traits like aggressiveness or risk-taking are not uniformly positive for success in sc

63 lly problematic substance use showed greater risk taking as well as lower striatal activation relativ

64 bility and loss in BD can potentially modify risk-taking attitudes, which have important public healt

65 se of ART might increase sexual or injecting risk-taking, available research suggests that unprotecte

66 vity Scale) and performance-based behavioral risk taking (Balloon Analogue Risk Task) in bipolar diso

67 -report and testosterone levels), laboratory risk-taking (balloon analog risk task; BART), and self-r

68 e quadratic pattern was found for laboratory risk-taking (BART).

69 Two perspectives on risk taking became apparent: the procedure-centric persp

70 This difference in risk taking because of AP medications was not explained

71 real versus hypothetical monetary rewards on risk taking behavior and brain activity, suggesting a ca

72 cence might have more predominant effects on risk-taking behavior (indexed by increases in open-arm a

73 tors of mental health disturbance, including risk-taking behavior (suicidality, self-mutilation, and

74 We assessed financial risk-taking behavior after 7 consecutive nights of sleep

75 ritical mediator of psychiatric symptoms and risk-taking behavior among sexually abused children.

76 pmental time point associated with increased risk-taking behavior and experimentation with drugs of a

77 ike receptor availability is correlated with risk-taking behavior and sensitivity of prefrontal activ

78 indings suggest dopaminergic augmentation of risk-taking behavior as a potential contributing mechani

79 chievement, and rates of chronic illness and risk-taking behavior at 20 years of age.

80 at right anodal/left cathodal would decrease risk-taking behavior compared with left anodal/right cat

81 opmental period marked by steep increases in risk-taking behavior coupled with dramatic brain changes

82 Increased risk-taking behavior has been associated with addiction,

83 models to more fully explore neurobiology of risk-taking behavior in adolescence.

84 novel neural mechanism underlying heightened risk-taking behavior in alcohol-dependent individuals an

85 These findings provide evidence that risk-taking behavior in humans can be directly manipulat

86 , we assessed the role of agonist therapy on risk-taking behavior in PD patients with (n = 22) and wi

87 Risk-taking behavior is characterized by pursuit of rewa

88 ear whether subjective value associated with risk-taking behavior is encoded by DA release.

89 The ability to modify risk-taking behavior may be translated into therapeutic

90 ty correlated with individual differences in risk-taking behavior observed after monetary losses, whe

91 sociated with changes in sexual or injecting risk-taking behavior or diagnosis of sexually transmitte

92 that adolescent alcohol use results in adult risk-taking behavior that positively correlates with pha

93 pharmacological approach to the reversal of risk-taking behavior through normalization of this patte

94 dual differences in pubertal development and risk-taking behavior were contributors to longitudinal c

95 Individual differences in risk-taking behavior were observed as animals displayed

96 owever, there was no difference in injecting risk-taking behavior with antiretroviral use (OR, 0.90;

97 Impulsivity, risk-taking behavior, and elevated stress responsivity a

98 Dopaminergic drugs are known to increase risk-taking behavior, but the underlying mechanisms for

99 terns were reliably predictive of subsequent risk-taking behavior, including a number of regions know

100 r persons with a history of substance abuse, risk-taking behavior, or suicidal ideation.

101 oding of reward outcomes was correlated with risk-taking behavior, with safe-preferring and risk-pref

102 IV prevention efforts by changing individual risk-taking behavior.

103 shown that disruption of the DLPFC increases risk-taking behavior.

104 mine signals in attention-based learning and risk-taking behavior.

105 n dopamine, a neuromodulator associated with risk-taking behavior.

106 e manifestations often include impulsive and risk-taking behavior.

107 me and contributes to adolescents' real-life risk-taking behavior.

108 animals exhibited individual differences in risk-taking behavior; some displayed a preference for th

109 Several of these risk-taking behaviors constituted a behavioral syndrome

110 the present study was to investigate whether risk-taking behaviors could be decreased using concurren

111 he risk of violence and other antisocial and risk-taking behaviors in adulthood has not been studied

112 isk for serious adverse events by increasing risk-taking behaviors in intoxicated or impaired persons

113 a critical developmental phase during which risk-taking behaviors increase across a variety of speci

114 e propensity of a putative therapy to induce risk-taking behaviors is of interest.

115 ors suggests that populations with boundless risk-taking behaviors leading to negative real-life cons

116 Adolescence has been characterized by risk-taking behaviors that can lead to fatal outcomes.

117 levant to numerous psychiatric disorders and risk-taking behaviors, and different lines of evidence h

118 d ethanol has been associated with increased risk-taking behaviors, harm to adolescent users, impaire

119 abnormalities, including self-injurious and risk-taking behaviors, hyperactivity, and learning and m

120 ameliorated PPI deficits, hyperactivity, and risk-taking behaviors, in a fashion akin to the antipsyc

121 This leads to characteristic risk-taking behaviors, including noncompliance with medi

122 ts, indoor tanning was associated with other risk-taking behaviors, such as binge drinking (P < .001

123 , abandon medication regimens, and engage in risk-taking behaviors.

124 and adolescents may not be forthcoming about risk-taking behaviors.

125 upraorbital area) was sufficient to decrease risk-taking behaviors.

126 lescent lifestyles or genetically determined risk-taking behaviors.

127 o be associated with increased engagement in risk-taking behaviors.

128 DLPFC by itself did not significantly change risk-taking behaviors; however, when the contralateral D

129 onsistency in, as well as average levels of, risk taking behaviour (i.e. boldness) when individuals w

130 role in financial markets through increased risk taking behaviour, acting via different behavioural

131 ACoA patients demonstrated true risk-taking behaviour as opposed to simple impulsivity.

132 aradigm, patients were found to show genuine risk-taking behaviour with increased deliberation times

133 ing Task to characterize decision-making and risk-taking behaviour, outside of a learning context, in

134 They did, however, exhibit increased risk-taking behaviour, placing higher bets in a measure

135 Similarly, the differences in risk taking between schizophrenia and bipolar disorder w

136 Voxel-based morphometry showed that greater risk-taking bias was also associated with and partially

137 Risk-taking bias was assessed by the Cambridge Gamble Ta

138 With increasing risk-taking bias, the ventral striatum showed decreased

139 Increased sexual risk taking by individuals using effective HIV preventio

140 ergen thresholds can result in confusion and risk taking by patients with food allergy.

141 ional bias to reward that potentially drives risk taking by priming approach behavior and elevating r

142 dance, reduced quality of life and increased risk-taking by consumers who often ignore PAL.

143 individuals exerted an overriding effect on risk-taking by the entire group, for reasons independent

144 Risk taking can be considered normal in adolescents with

145 sistency, independently of average levels of risk-taking, can be advantageous: more consistent indivi

146 tudy to examine how neural activation during risk taking changes over time and contributes to adolesc

147 ssociated with impulsive decision making and risk taking, characteristics that may arise from hyperse

148 ger attacks/aggression, substance abuse, and risk taking compared with women.

149 lesions, OFC lesions significantly decreased risk-taking compared with sham controls, but did not imp

150 ed choice of the large risky reward (greater risk-taking) compared to both prelesion performance and

151 Impulsive risk taking contributes to deleterious outcomes among cl

152 onal Personality Questionnaire indicators of risk-taking (d = 0.50) and impulsivity (d = 0.56).

153 on examined whether insula activation during risk-taking decisions-a process shown to be disrupted in

154 ar if this is due to changes in impulsivity, risk taking, deliberation or risk adjustment, and how th

155 e show that this generosity is not caused by risk-taking deviations in nonsocial contexts.

156 nd striatal activation by pump number during risk taking differed with group.

157 o controls suggesting increased activity and risk taking, diminished short term memory, and decreased

158 pant were extracted from the Domain Specific Risk Taking (DOSPERT) scales.

159 determine whether individual differences in risk taking during adolescence predict later propensity

160 rom these experiments indicated that greater risk taking during adolescence predicted greater intake

161 is also a time of increased exploration and risk-taking (e.g., drug use).

162 to better understand the root causes of MSM risk-taking (e.g., poverty, sex work, substance abuse, m

163 PFC, which may contribute to impulsivity and risk-taking exhibited by adolescents [5, 6, 10-12].

164 on impulsivity [F(1,9) = 7.86, P = 0.02] and risk taking [F(1,9) = 9.2, P = 0.01] in the context of g

165 Risk-taking has a fourfold pattern varying as a function

166 g emotional expressions, as well as empathy, risk taking, impulsivity, behavior change, and attention

167 Might increased risk taking in adolescence result in part from underdeve

168 tory and real-world measures of individuals' risk taking in adulthood.

169 Next, we estimated economic risk taking in daily life using large-scale data from in

170 Here we demonstrate abnormal risk taking in DYT1 dystonia patients, which is correlat

171 Studies have shown increased risk taking in healthy individuals after low-frequency r

172 e relationship between dopamine agonists and risk taking in patients with Parkinson's disease with an

173 ationally, such asymmetric learning predicts risk taking in probabilistic tasks.

174 of real and hypothetical monetary rewards on risk taking in the brain.

175 Both groups similarly reduced their risk-taking in high compared to low risk conditions and

176 otherapies for disorders involving excessive risk-taking in humans, such as pathological gambling.

177 Here we assess these influences on risk-taking in patients with pathological behaviors towa

178 DAA increased risk-taking in PD patients with active ICD symptoms, but

179 ersely associated with trait impulsivity and risk-taking in the bipolar disorder group.

180 paper applies the theory of the evolution of risk-taking in the presence of idiosyncratic and environ

181 ing disorder in obesity with similarities in risk-taking in the reward domain to substance use disord

182 ifferent dopamine receptor subtypes modulate risk-taking in young adult rats, using a "Risky Decision

183 al inefficiency, but not punishment-mediated risk-taking, in adulthood.

184 ses to spatial locations and their levels of risk-taking, indicated by betting, and impulsivity, meas

185 Theory on condition-dependent risk-taking indicates that when prey are in poor conditi

186 consequence effects are strikingly absent in risk-taking individuals.

187 emporal areas dissociated risk-aversive from risk-taking individuals.

188 ing geographically distinct clusters at high risk, taking into account realistic logistical constrain

189 ported ICD is pathological gambling of which risk taking is a prominent feature.

190 k and benefit are inherently subjective, and risk taking is best understood as the interplay between

191 Risk taking is central to human activity.

192 addition, the RDT was used to determine how risk taking is modulated by dopamine signaling, particul

193 preparing to engage in one, suggesting that risk taking may be due, in part, to a failure of the con

194 Risk taking may be the result of differential maturation

195 se anxiety manipulations; and (ii) decreased risk-taking may be specific to pathological anxiety.

196 ase (ORs of two to three), strong for sexual risk taking, mental ill health, and problematic alcohol

197 is finding suggests that the higher level of risk-taking observed among adolescents may reflect a hig

198 learning allows animals to capitalize on the risk-taking of others, and avoid endangering themselves,

199 nts approach more robust incentives (such as risk taking or drug experimentation) to recruit this cir

200 erences in different choice domains, such as risk taking or saving, and how preferences in different

201 Poor decision making and elevated risk taking, particularly during adolescence, have been

202 g behavior are mild enough to encourage some risk taking, predecision PMC activation by a reward/risk

203 One unanswered question is whether risk-taking preference is associated with striatal rewar

204 and ESR1), irritable temperament (MSRA) and risk-taking propensity (CADM2).

205 is often described as a period of increased risk taking relative to both childhood and adulthood.

206 eater levels of novelty-seeking behavior and risk-taking relative to adults, behaviors associated in

207 ernization is associated with greater sexual risk-taking, report prevalence of gynecological morbidit

208 ulant addiction is often linked to excessive risk taking, sensation seeking, and impulsivity, but in

209 , might not result in substantial changes in risk-taking sexual behaviour by heterosexual couples.

210 ects with binge eating disorder show greater risk-taking, similar to substance-use disorders.

211 n-diabetic patients with high cardiovascular risk, taking statins.

212 g a pharmacological manipulation and a novel risk taking task while performing functional magnetic re

213 Using an anticipatory risk-taking task (40 BD and 70 healthy volunteers) and a

214 f healthy subjects performing a naturalistic risk-taking task and used a classification analysis appr

215 program during early abstinence completed a risk-taking task during functional magnetic resonance im

216 activation decreased during an experimental risk-taking task over time, with greater declines in VLP

217 k) and the balloon analog risk task (BART; a risk-taking task), and we measured their chronotype in t

218 On the risk-taking task, schizophrenia patients were significan

219 n analog risk task; BART), and self-reported risk-taking tendency (Behavior Inhibition System/Behavio

220 ertal hormones and individual differences in risk-taking tendency.

221 s), laboratory risk-taking and self-reported risk-taking tendency; and (2) to test whether individual

222 self-administration in turn caused elevated risk taking that was present following 6 weeks of abstin

223 stimuli in the hungriest animals may reflect risk-taking that can enhance prey capture success.

224 al cortex is thought to influence adolescent risk taking, the specific ways in which it functions are

225 rontal cortex (PFC) may influence adolescent risk taking, the specific ways in which it functions rem

226 le decreased real life measures of financial risk taking through its influence on neuroticism.

227 Specifically, the stress response calibrates risk taking to our circumstances, reducing it in times o

228 Ex-smokers also had lower risk-taking to rewards compared with non-smokers.

229 hanisms for adaptively adjusting behavioural risk-taking to the current situation.

230 conomically influential class of competitive risk taking-trading in the financial world.

231 Humanity's fossil-fuel use, if unabated, risks taking us, by the middle of the twenty-first centu

232 tal health problems are related to increased risk taking via inconsistent condom use, multiple partne

233 whereas the medial PFC influences adolescent risk taking via its functional neural coupling with rewa

234 Greater adolescent risk taking was associated with lower striatal D2 recept

235 This effect of unequal distributions on risk taking was driven by upward social comparisons.

236 Risk taking was higher in states with greater income ine

237 tion between ADHD symptoms and engagement in risk taking was mediated by perceived benefits.

238 with cathodal tCDS, an important decrease in risk taking was observed.

239 ndicating that lesion-induced alterations in risk-taking were not secondary to changes in appetitive

240 ral PFC are linked to declines in adolescent risk taking, whereas the medial PFC influences adolescen

241 ion of D2-like receptors robustly attenuated risk-taking, whereas drugs acting on D1-like receptors h

242 decreasing the left, might lead to decreased risk taking, which could hold clinical relevance as exce

243 lighted adolescence as a period of increased risk-taking, which is postulated to result from an overa

244 nsular cortex was positively associated with risk-taking, while D2 mRNA expression in orbitofrontal a

245 ivity (FRN) in response to money loss during risk taking with real rewards compared to those with hyp